Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
DNLI Denali Therapeutics
- 14.420
- -0.530-3.55%
Trading Mar 11 10:23 ET
2.09BMarket Cap-5.61P/E (TTM)
14.950High14.260Low150.28KVolume14.950Open14.950Pre Close2.19MTurnover0.11%Turnover RatioLossP/E (Static)145.22MShares33.33052wk High1.70P/B1.89BFloat Cap14.01052wk Low--Dividend TTM131.34MShs Float93.940Historical High--Div YieldTTM4.62%Amplitude12.320Historical Low14.568Avg Price1Lot Size
Denali Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 204.74%330.53M | 0 | -64.40%1.27M | 460.45%294.12M | -16.61%35.14M |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | 214.60%330.53M | --0 | 588.59%1.27M | 460.45%294.12M | -16.61%35.14M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -4.81%501.88M | -2.06%129.85M | 7.06%123.19M | -5.70%116.59M | -15.20%132.25M | 17.37%527.23M | 14.65%132.57M | 3.62%115.06M | 8.56%123.64M | 43.55%155.96M |
| Selling and administrative expenses | 2.02%105.44M | 21.36%30.06M | -1.48%24.95M | -3.55%25.19M | -7.02%25.24M | 14.23%103.35M | 5.33%24.77M | 8.88%25.33M | 23.45%26.12M | 20.40%27.14M |
| -General and administrative expense | 2.02%105.44M | 21.36%30.06M | -1.48%24.95M | -3.55%25.19M | -7.02%25.24M | 14.23%103.35M | 5.33%24.77M | 8.88%25.33M | 23.45%26.12M | 20.40%27.14M |
| Research and development costs | -6.47%396.44M | -7.44%99.79M | 9.47%98.24M | -6.28%91.4M | -16.92%107.02M | 18.16%423.88M | 17.04%107.8M | 2.22%89.74M | 5.16%97.52M | 49.62%128.82M |
| Operating profit | -155.15%-501.88M | 2.06%-129.85M | -8.25%-123.19M | -168.39%-116.59M | -9.47%-132.25M | 42.27%-196.7M | -25.85%-132.57M | -5.87%-113.8M | 377.59%170.48M | -81.68%-120.82M |
| Net non-operating interest income expense | 25.49%64.64M | 15.48%15.16M | 10.75%16M | 36.18%17.57M | 44.22%15.91M | 248.62%51.51M | 97.13%13.13M | 244.92%14.44M | 386.98%12.9M | 763.38%11.03M |
| Non-operating interest income | 25.49%64.64M | 15.48%15.16M | 10.75%16M | 36.18%17.57M | 44.22%15.91M | 248.62%51.51M | --13.13M | --14.44M | 386.98%12.9M | 763.38%11.03M |
| Other net income (expense) | 14.54M | 0 | 14.54M | |||||||
| Special income (charges) | --14.54M | --0 | --0 | --0 | --14.54M | --0 | --0 | --0 | --0 | --0 |
| -Gain on sale of business | --14.54M | --0 | --0 | --0 | --14.54M | --0 | --0 | --0 | --0 | --0 |
| Income before tax | -191.13%-422.71M | 3.98%-114.69M | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.46%-145.19M | -21.04%-119.44M | 3.82%-99.35M | 412.05%183.38M | -68.32%-109.78M |
| Income tax | 126.67%68K | 42.86%30K | ||||||||
| Net income | -191.12%-422.77M | 3.95%-114.75M | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M | -68.32%-109.78M |
| Net income continuous Operations | -191.12%-422.77M | 3.95%-114.75M | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M | -68.32%-109.78M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -191.12%-422.77M | 3.95%-114.75M | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M | -68.32%-109.78M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -191.12%-422.77M | 3.95%-114.75M | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M | -68.32%-109.78M |
| Basic earnings per share | -142.45%-2.57 | 22.09%-0.67 | 12.50%-0.63 | -144.03%-0.59 | 15.00%-0.68 | 59.23%-1.06 | -14.67%-0.86 | 14.29%-0.72 | 379.17%1.34 | -50.94%-0.8 |
| Diluted earnings per share | -142.45%-2.57 | 22.09%-0.67 | 12.50%-0.63 | -145.38%-0.59 | 15.00%-0.68 | 59.23%-1.06 | -14.67%-0.86 | 14.29%-0.72 | 370.83%1.3 | -50.94%-0.8 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |